InvestorsHub Logo
Followers 165
Posts 19913
Boards Moderated 2
Alias Born 12/09/2004

Re: Kb1123 post# 294918

Saturday, 01/30/2021 1:24:51 AM

Saturday, January 30, 2021 1:24:51 AM

Post# of 464617
Yes the potential patients know they are taking 2-73, an investigational new drug for the treatment of AD.

That is all part of informed consent.

They also know there is a chance they could be assigned to the placebo group and not receive any 2-73. Of course since it is a blinded trial they will not know if the pill they receive is 2-73 or the placebo.

They do know that at the end of the trial they will be able to receive 2-73 in the open label extension part of the trial whether they were in the placebo group or one of the trial arms receiving 2-73.

The American Republic will endure until the day Congress discovers that it can bribe the public with its own money.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News